Clinical trial
Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
NCT04867707 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 14, 2021
- Completion date
- October 18, 2024
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.